Does tumour dormancy offer a therapeutic target?
Journal: 2011/January - Nature Reviews Cancer
ISSN: 1474-1768
Abstract:
The increasing number of cancer survivors is cause for celebration, but this expanding population has highlighted the problem of tumour dormancy, which can lead to relapse. As we start to understand more about the biology of dormant cancer cells, we can begin to address how best to treat this form of disease. Preclinical models and initial clinical trials, as exemplified in patients with breast cancer, are paving the way to address how best to treat long-term cancer survivors to minimize the risk of cancer recurrence.
Relations:
Citations
(116)
References
(71)
Diseases
(1)
Conditions
(2)
Chemicals
(1)
Organisms
(2)
Anatomy
(1)
Affiliates
(2)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.